SynthesisChemistry & biodiversity2026
Endophytic Fungi Natural Factories of Novel Bioactive Compounds.
Synthesis in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Endophytic fungi represent a prolific and chemically diverse source of novel specialized metabolites with significant pharmacological potential. This systematic review examines 118 studies published between 2024 and 2025, reporting the discovery of 242 previously uncharacterized bioactive compounds. These metabolites belong to several major chemical classes, including peptides (4), terpenoids and steroids (58), alkaloids and other nitrogen-containing compounds (51), polyketides (85), lactones (22), ketones (5), chromone compounds (3), and others (9). The genera Aspergillus (28), Penicillium (21), Diaporthe (7), Talaromyces (10), and Trichoderma (6) were identified as the most productive sources. The investigated endophytic fungi were isolated from a wide range of plant hosts and ecological niches, reflecting the extensive biodiversity of endophytic communities. Biological screening demonstrated that a substantial proportion of the tested compounds exhibited diverse bioactivities, including anti-inflammatory, antibacterial, antifungal, antimicroalgal, and cytotoxic effects. Collectively, the remarkable structural diversity and broad biological profiles of metabolites derived from endophytic fungi highlight their strong potential as promising lead scaffolds for future pharmaceutical development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.